Systematic intensification of red cell exchange with hydroxyurea decreased the transfusion burden in patients with sickle cell disease: A single-center retrospective cohort study
Cohort study shows systematic addition of hydroxyurea reduces transfusion burden in sickle cell disease, suggesting improved treatment management.
Key Points
Sickle cell disease patients experienced a mild decrease in transfusion burden after hydroxyurea was introduced—indicating enhanced treatment efficacy.
The cumulative number of transfused red blood cells per patient decreased significantly from 81.7 units to 76.2 units after hydroxyurea initiation.
The cohort study methodology incorporated a pre–post design, allowing each patient to serve as their control.
Further research is necessary to assess long-term outcomes and impacts on iron balance and quality of life.